Overview
Axol Bioscience specializes in high-quality induced pluripotent stem cell (iPSC) products and services to support drug discovery and R&D. Key offerings include axoLines™ (over 70 characterized iPSC lines), axoCells™ (functional iPSC-derived cells like neurons and cardiomyocytes), axoServices™ (custom lab services), and axoModels™ (collaborative iPSC-based models). The company focuses on neurodegenerative diseases, peripheral nervous system disorders, and cardiotoxicity, with manufacturing under ISO 9001 at sites in the UK.
Frequently asked questions
- What iPSC-derived cell types does Axol Bioscience offer?
- Axol provides high-quality axoCells™ including neuronal cells (astrocytes, cortical excitatory neurons, microglia), sensory neurons for pain and touch, and chamber-specific cardiomyocytes (atrial and ventricular) for cardiotoxicity studies.
- What regulatory standards does Axol Bioscience follow?
- Manufacturing occurs at scale under ISO 9001 guidelines at the Roslin Innovation Centre in the UK, ensuring quality and consistency for iPSC products.
- Where are Axol Bioscience's facilities located?
- Axol operates two main UK sites: a manufacturing facility at Roslin Innovation Centre in Easter Bush and an R&D hub at Babraham Research Campus in Cambridge, serving customers globally.